Insulin resistance in hidradenitis suppurativa: a case-control study
EstadísticasView Usage Statistics
Full recordShow full item record
AuthorVilanova Urdaniz, Iosune; Hernández Hernández, José Luis; Mata Arnaiz, María Cristina; Durán, C; García Unzueta, María Teresa; Portilla González, Virginia; Fuentevilla Rodríguez, Patricia; Corrales Martínez, Alfonso; González Vela, María del Carmen; González-Gay Mantecón, Miguel Ángel; Blanco Alonso, Ricardo; González López, Marcos Antonio
© European Academy of Dermatology and Venereology. Published by Wiley. This is the peer reviewed version of the following article: Insulin resistance in hidradenitis suppurativa: a case-control study, which has been published in final form at https://doi.org/10.1111/jdv.14894. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
J Eur Acad Dermatol Venereol. 2018 May;32(5):820-824
Background: The association between chronic inflammatory diseases, such as rheumatoid arthritis and psoriasis, and insulin resistance (IR) has been well established. Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease that affects the apocrine glandbearing areas of the body. Objective: We aimed to determine the prevalence of IR in patients with HS. Methods: This cross-sectional, case-control study enrolled 137 subjects, 76 patients with HS and 61 age- and gender-matched controls. Demographic data, clinical examination of HS patients, anthropometric measures, cardiovascular risk factors and laboratory studies were recorded. The homeostasis model assessment of IR (HOMA-IR) was calculated in all participants by measuring fasting plasma glucose and insulin levels. Results: The median (IQR) HOMA-IR value in HS patients was significantly higher [2.0 (1.0-3.6)] than in controls [1.5(0.9-2.3)] (p=0.01). The prevalence of IR was significantly higher in cases (43.4%) compared with controls (16.4%) (p=0.001). In the linear regression multivariable analysis after adjusting for age, sex and body mass index (BMI), HS remained as a significant factor for a higher HOMA-IR [2.51(0.18) vs 1.92(0.21); p=0.04]. The HOMA-IR value and the prevalence of IR did not differ significantly among HS patients grouped by severity of the disease. Conclusion: Our results show an increased frequency of IR in HS. Thus, we suggest HS patients to be evaluated for IR and managed accordingly.